1. Home
  2. FEBO vs WGSWW Comparison

FEBO vs WGSWW Comparison

Compare FEBO & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEBO
  • WGSWW
  • Stock Information
  • Founded
  • FEBO 1993
  • WGSWW 2017
  • Country
  • FEBO Hong Kong
  • WGSWW United States
  • Employees
  • FEBO N/A
  • WGSWW N/A
  • Industry
  • FEBO
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • Sector
  • FEBO
  • WGSWW Technology
  • Exchange
  • FEBO Nasdaq
  • WGSWW Nasdaq
  • Market Cap
  • FEBO N/A
  • WGSWW N/A
  • IPO Year
  • FEBO 2023
  • WGSWW N/A
  • Fundamental
  • Price
  • FEBO $1.17
  • WGSWW $0.17
  • Analyst Decision
  • FEBO
  • WGSWW
  • Analyst Count
  • FEBO 0
  • WGSWW 0
  • Target Price
  • FEBO N/A
  • WGSWW N/A
  • AVG Volume (30 Days)
  • FEBO 8.1K
  • WGSWW 36.6K
  • Earning Date
  • FEBO 04-24-2025
  • WGSWW 02-18-2025
  • Dividend Yield
  • FEBO N/A
  • WGSWW N/A
  • EPS Growth
  • FEBO N/A
  • WGSWW N/A
  • EPS
  • FEBO N/A
  • WGSWW N/A
  • Revenue
  • FEBO $16,319,897.00
  • WGSWW $305,450,000.00
  • Revenue This Year
  • FEBO N/A
  • WGSWW N/A
  • Revenue Next Year
  • FEBO N/A
  • WGSWW N/A
  • P/E Ratio
  • FEBO N/A
  • WGSWW N/A
  • Revenue Growth
  • FEBO 9.01
  • WGSWW 50.79
  • 52 Week Low
  • FEBO $0.93
  • WGSWW $0.17
  • 52 Week High
  • FEBO $17.68
  • WGSWW $0.21
  • Technical
  • Relative Strength Index (RSI)
  • FEBO 47.19
  • WGSWW N/A
  • Support Level
  • FEBO $1.11
  • WGSWW N/A
  • Resistance Level
  • FEBO $1.46
  • WGSWW N/A
  • Average True Range (ATR)
  • FEBO 0.12
  • WGSWW 0.00
  • MACD
  • FEBO 0.01
  • WGSWW 0.00
  • Stochastic Oscillator
  • FEBO 22.14
  • WGSWW 0.00

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: